By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Waltham, Massachusetts) 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug 2/17/2017 7:04:09 AM
Tesaro (TSRO) To Announce Fourth-Quarter 2016 Financial Results On February 28, 2017 2/15/2017 8:03:43 AM
Tesaro (TSRO) Announces Participation At Two Investor Conferences 2/3/2017 8:54:28 AM
Tesaro (TSRO) Biotech Announces Opening Of Niraparib Expanded Access Program For U.S. Patients With Ovarian Cancer 1/17/2017 6:58:00 AM
Tesaro (TSRO) Craters as the FDA Denies Approval of Rolapitant IV 1/12/2017 5:39:41 AM
Tesaro (TSRO) Announces Priority Review Designation For Niraparib NDA 12/20/2016 8:56:39 AM
Tesaro (TSRO) Announces Participation In Three Investor Conferences 11/22/2016 7:57:51 AM
Tesaro (TSRO) Announces Proposed Public Offering Of Common Stock 11/14/2016 10:02:42 AM
With Donald Trump as President, Here’s What Biotech M&A and Drug Pricing Could Look Like (and Renewed Takeover Interest for Tesaro (TSRO) and Sarepta (SRPT) 11/11/2016 5:56:11 AM
Tesaro (TSRO) Announces Third-Quarter 2016 Operating Results 11/4/2016 9:18:22 AM